CD34 and acute myeloid leukemia: Therefore, AML-PDX (HLA-A3+HLA-B7−) mice were transplanted with mismatched human PB CD34+cells (HLA-A3− HLA-B7+) 4 days post-CD117×CD3 BTCE treatment.